Perspective on Updated Treatment Guidelines for Patients With Gastrointestinal Stromal Tumors

Por Blay, Jean-Yves, von Mehren, Margaret, Blackstein, Martin E.
Publicado em 2010

Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups

Por Waddell, Andrea E., Davis, Aileen M., Ahn, Henry, Wunder, Jay S., Blackstein, Martin E., Bell, Robert S.
Publicado em 1999

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study

Por Angarita, Fernando A., Cannell, Amanda J., Abdul Razak, Albiruni R., Dickson, Brendan C., Blackstein, Martin E.
Publicado no BMC Cancer (2016)

Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prosp...

Por Nottage, Michelle K, Kopciuk, Karen A, Tzontcheva, Anjela, Andrulis, Irene L, Bull, Shelley B, Blackstein, Martin E
Publicado em 2006

Gastrointestinal stromal tumours: Consensus statement on diagnosis and treatment

Por Blackstein, Martin E, Blay, Jean-Yves, Corless, Christopher, Driman, David K, Riddell, Robert, Soulières, Denis, Swallow, Carol J, Verma, Shailendra
Publicado em 2006

A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma

Por Morris, Don G., Bramwell, Vivien H. C., Turcotte, Robert, Figueredo, Alvaro T., Blackstein, Martin E., Verma, Shail, Matthews, Sarah, Eisenhauer, Elizabeth A.
Publicado em 2006

Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI

Por Ingley, Katrina M., Burtenshaw, Sally M., Theobalds, Nicole C., White, Lawrence M., Blackstein, Martin E., Gladdy, Rebecca A., Thipphavong, Seng, Gupta, Abha A.
Publicado no Cancer Med (2019)

Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience

Por Weiss, Kurt R., Biau, David J., Bhumbra, Rej, Griffin, Anthony M., Blackstein, Martin E., Chung, Peter, Catton, Charles, O'Sullivan, Brian, Ferguson, Peter C., Wunder, Jay S.
Publicado em 2011

Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib Failure

Por DePrimo, Samuel E., Huang, Xin, Blackstein, Martin E., Garrett, Christopher R., Harmon, Charles S., Schöffski, Patrick, Shah, Manisha H., Verweij, Jaap, Baum, Charles M., Demetri, George D.
Publicado em 2009

Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized, Primary Gastrointestinal Stromal Tumor (GIST)

Por DeMatteo, Ronald P., Ballman, Karla V., Antonescu, Cristina R., Maki, Robert G., Pisters, Peter W.T., Demetri, George D., Blackstein, Martin E., Blanke, Charles D., von Mehren, Margaret, Brennan, Murray F., Patel, Shreyaskumar, McCarter, Martin D., Polikoff, Jonathan A., Tan, Benjamin R., Owzar, Kouros
Publicado em 2009

Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

Por Corless, Christopher L., Ballman, Karla V., Antonescu, Cristina R., Kolesnikova, Violetta, Maki, Robert G., Pisters, Peter W.T., Blackstein, Martin E., Blanke, Charles D., Demetri, George D., Heinrich, Michael C., von Mehren, Margaret, Patel, Shreyaskumar, McCarter, Martin D., Owzar, Kouros, DeMatteo, Ronald P.
Publicado em 2014

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors with Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033

Por Heinrich, Michael C., Rankin, Cathryn, Blanke, Charles D., Demetri, George D., Borden, Ernest C., Ryan, Christopher W., von Mehren, Margaret, Blackstein, Martin E., Priebat, Dennis A., Tap, William D., Maki, Robert G., Corless, Christopher L., Fletcher, Jonathan A., Owzar, Kouros, Crowley, John J., Benjamin, Robert S., Baker, Laurence H.
Publicado no JAMA Oncol (2017)